Loading insider details...
Beta
Latest Form 4 (Aug 17, 2026): Exercise/Conversion of 326,618 SGMT shares, $2.08M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 17, 2026 | Sagimet Biosciences Inc. (SGMT) | Exercise/Conversion | 326,618 | $2.08M |
| Aug 12, 2026 | Sagimet Biosciences Inc. (SGMT) | Exercise/Conversion | 9,751 | $62.0K |
| Jul 22, 2026 | Sagimet Biosciences Inc. (SGMT) | Sale | 18,844 | $140.5K |
| Jun 15, 2026 | Sagimet Biosciences Inc. (SGMT) | Grant/Award | 39,567 | n/a |
| Nov 21, 2025 | Sagimet Biosciences Inc. (SGMT) | Sale | 37,688 | $290.0K |
| Jun 10, 2025 | Sagimet Biosciences Inc. (SGMT) | Grant/Award | 32,250 | n/a |
| Jul 25, 2024 | Sagimet Biosciences Inc. (SGMT) | Sale | 23,625 | $74.8K |
| Jul 23, 2024 | Sagimet Biosciences Inc. (SGMT) | Sale | 14,062 | $43.6K |
| Nov 21, 2023 | Sagimet Biosciences Inc. (SGMT) | Grant/Award | 150,750 | n/a |
| Sep 8, 2023 | Sagimet Biosciences Inc. (SGMT) | Exercise/Conversion | 5,630 | $4.4K |